The new trial makes mRNA vaccines personalized, taking an individual’s unique tumor cells. Seven out of the study’s eight ...

With the introduction of mRNA vaccines in the 2010s – vaccines that use messenger RNA molecules in cells to train the body to ...

The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.

Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are ...

Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat. CAMBRIDGE, MA / ACC ...

This week, the European Commission authorized Moderna to market the vaccine, mRNA-1083 or mCOMBRIAX, making it the world’s ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

Starting this autumn, adults aged 50 and older across the European Union may be able to roll up their sleeve just once and ...

The Department of Health and Human Services had canceled hundreds of millions of dollars in funding previously committed help ...